Scorpion Capital disclosed a short position in Soleno Therapeutics on Friday, citing issues with the drugmaker's recently approved treatment Vykat XR, sending its shares slumping 15% in premarket ...

Soleno Therapeutics Inc (NASDAQ:SLNO) stock fell 13% Friday morning following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

The shortseller alleged several risks associated with Vykat XR, including high risk of pre-diabetes/diabetes, pulmonary edema ...

Soleno Therapeutics (SLNO) dropped 16% in premarket trading after a new short report from Scorpion Capital. Scorpion Capital ...

How to beat Scorpions in Grounded 2 Pick up on how the Grounded 2 scorpions do battle and you shouldn't have too much trouble taking on one of the park's most dangerous bugs.

Execution risks, such as scaling production and meeting quality standards, persist, compounded by past controversies like a 2021 Scorpion Capital report questioning the company’s viability.

The most eye-catching feature of Annaly Capital Management 's (NYSE: NLY) stock is its 14%+ dividend yield. There are some strong reasons to consider buying the mortgage real estate investment ...

Capital gains taxes are back in the spotlight. This time, the chatter on Capitol Hill has to do with rising home prices.

Annaly Capital Management is a mortgage REIT, a complex corner of the REIT sector. The company has a huge 14%+ dividend yield and it increased its dividend in 2025. There are reasons to like ...

Lake Shore Bancorp raised nearly $50 million in capital as it completed a conversion to a fully publicly traded company.